Buy Cardarine GW501516 Oral Suspension.
Buy Cardarine GW501516 Oral Suspension is a research chemical that was developed in the 1990’s to prevent and cure tumor formation in the colon, prostate and breasts in humans.
What is Cardarine GW501516?
GW501516 (or Cardarine) is a research chemical that was developed in the 1990’s to prevent and cure tumor formation in the colon, prostate and breasts in humans.
Studies that were done in the early 2000’s have found that GW 501516 and other PPAR agonists have also been able to stop metabolic disorders such as obesity and diabetes through specific gene expressions.
Use of Cardarine GW501516:
Cardarine’s ability to burn off excess fatty tissue, enhance recovery and dramatically increase endurance has made this product a staple in every athlete’s cycle and PCT.
With no harmful side effects found in the past 20 years, no wonder why Cardarine has become a legend in the world of sports and athleticism.
Where to buy Cardarine:
We are 100% legit and efficient supplier of performance supplements. We offer the best market prices and offer a huge discount for bulk buyers.
Packaging and shipping are very discreet and bypass all custom or law enforcement. Delivery through regular and express airmail within 2-3 business days from dispatch.
For more information or a special quotation, do not hesitate to contact us.
GW501516 was initially discovered during a research collaboration between GSK and Ligand Pharmaceuticals that began in 1992.
The discovery of the compound was published in a 2001 issue of PNAS.
Oliver et al. reported that they used “combinatorial chemistry and structure-based drug design” to develop it.
One of the authors was the son of Leo Sternbach who discovered benzodiazepines in the 1960s.
Concerns were raised prior to the 2008 Beijing Olympics that GW501516 could be used by athletes as an ergogenic performance-enhancing drug that was not currently controlled by regulations or detected by standard tests.
One of the main researchers from the study on enhanced endurance consequently developed a urine test to detect the drug, and made it available to the International Olympic Committee.
The World Anti-Doping Agency (WADA) developed a test for GW501516 and other related PPARδ modulators, and added such drugs to the prohibited list in 2009.